EVRYSDI Dry Syrup 60 mg General Drug Use Surveillance (All-Patient Surveillance) -Spinal Muscular Atrophy-
Latest Information Update: 08 Jan 2022
At a glance
- Drugs Risdiplam (Primary)
- Indications Spinal muscular atrophy
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 06 Sep 2021 New trial record